SCHEMBL17995351

SCHEMBL17995351

c1ccc(-c2nc(-c3ccccc3)nc(-c3nc(-c4ccccc4)nc(-c4cc5c6ccccc6ccc5c5ccccc45)n3)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 4/20 0.48
MAPT P10636 5/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 2/20 0.47
NPC1 O15118 1/20 0.47
RECQL P46063 1/20 0.47
RAB9A P51151 1/20 0.47
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 4/20 0.41
TSHR P16473 4/20 0.41
HPGD P15428 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPK1 P28482 2/20 0.41
ATM Q13315 2/20 0.41
TP53 P04637 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19271418 0.98 HPRT1 (0.50) HPRT1MAPTSMN1; SMN2LMNANPC1
SCHEMBL26031573 0.93 TSHR (0.46) HPRT1MAPTSMN1; SMN2LMNANPC1
SCHEMBL17932614 0.91 MAPT (0.43) HPRT1MAPTSMN1; SMN2LMNANPC1
SCHEMBL25466562 0.91 MAPT (0.43) HPRT1MAPTSMN1; SMN2LMNANPC1
SCHEMBL21309357 0.90 HPRT1 (0.48) HPRT1MAPTSMN1; SMN2LMNANPC1
SCHEMBL12014657 0.89 MAPT (0.42) HPRT1MAPTSMN1; SMN2LMNANPC1
SCHEMBL12200478 0.89 L3MBTL1 (0.50) MAPTSMN1; SMN2LMNANPC1RAB9A
SCHEMBL17995339 0.87 CYP11B1 (0.51) MAPTSMN1; SMN2LMNANPC1RECQL
SCHEMBL23759491 0.87 HPRT1 (0.45) HPRT1MAPTSMN1; SMN2LMNANPC1
SCHEMBL24473151 0.87 MAPT (0.41) HPRT1MAPTSMN1; SMN2LMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10418562-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-09-17 US disclosed
US-20160233429-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2016-08-11 US disclosed
US-20160233429-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2016-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10418562-B2 Organic electroluminescent materials and devices NBAS, TBCB, SLC1A2 HPRT1 61/4885MAPT 304/4885SMN1; SMN2 4180/4885
US-20160233429-A1 Organic Electroluminescent Materials and Devices NBAS, TBCB, SLC1A2 HPRT1 61/4885MAPT 304/4885SMN1; SMN2 4180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.